Short-Term Debt to Capital: Bioventus (BVS)

bioventus.com - graphic logo of issuer BVS

The price history of Bioventus Inc. (BVS) on the GURU.Markets platform reflects the dynamics of a company whose business relies on a complex transportation system for biological preparations requiring strict temperature control. Proprietary joint solutions provide a stable income stream, while the indicator stands at 0.08. Meanwhile, significant debt obligations and government regulation of healthcare costs remain serious challenges.

BVS - Bioventus Inc Short-Term Debt to Capital Coefficient over the range 07/04/2022 - 10/31/2026
Signature product of bioventus.com

This indicator determines the investment reliability of Bioventus Inc. (BVS) by comparing the volume of liabilities with a maturity of over one year against the amount of equity to assess the risk of cash flow gaps. By analyzing changes in the share of short-term loans relative to equity, an investor can identify a critical debt load which, combined with regulatory pressure on medical procedure pricing, threatens the issuer's financial stability.

Competitor analysis for Bioventus Inc.

Short-Term Debt to Capital BSX|EW - Current Liabilities to Capital|Short-Term Debt to Capital RMD (ResMed Inc.)|PODD - Short-Term Debt to Equity Ratio|Zimmer Biomet Holdings - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient The Cooper Companies, Inc. COO|ALGN: Short-Term Debt to Capital|NuVasive (GMED) - Short-Term Debt to Capital|Short-Term Debt to Equity TransMedics Group Inc|Short-Term Debt to Equity ATEC|Short-Term Debt to Capital AORT|Short-Term Debt to Capital Coefficient Enovis Corp|Integra - Short-Term Debt to Equity Ratio|ESTA (Establishment Labs Inc) - Current Liabilities to Equity|Beta Bionics Inc - Short-Term Debt to Capital|Current Liabilities to Capital iradimed.com|EMBC: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio TNDM|Short-Term Debt to Equity Ratio AXGN|SIBN: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Orthofix Medical Inc. (OFIX)|Short-Term Debt to Equity Ratio orthopediatrics.com KIDS|Short-Term Debt to Capital TMCI (Treace Medical Concepts, Inc.)|Blade Air Mobility (SRTA) - Current Liabilities to Capital|Carlsmed Corp - Short-Term Debt to Capital|RXST (RxSight Ophthalmic) - Short-Term Debt to Capital Ratio|CLPT: Short-Term Debt to Capital|STXS - Short-Term Debt to Capital Coefficient|STIM (Neuronetics) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Sight Sciences Inc. (SGHT)|Short-Term Debt to Capital OBIO|Short-Term Debt to Capital anikatherapeutics.com (ANIK)|Short-Term Debt to Equity InspireMD, Inc. NSPR|Jin Medical International Ltd. - Short-Term Debt to Equity|VANI: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital XTNT (Xtant Medical Holdings)|NMTC: Short-Term Debt to Capital|Current Liabilities to Capital Modular Medical, Inc. (MODD)|Short-Term Debt to Equity Myomo, Inc.|COCH - Short-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio VVOS (Vivos Therapeutics, Inc.)|Short-Term Debt to Capital enVVeno Medical Corporation (NVNO)|Short-Term Debt to Capital SINT (Sintx Technologies, Inc.)|Short-Term Debt to Capital Coefficient Tenon Medical Inc (TNON)|LFWD - Short-Term Debt to Equity|Current Liabilities to Equity AMIX|INVO Fertility (IVF) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Bone Biologics Corp.|AXNX (Axonics Modulation Technologies) - Short-Term Debt to Capital|Current Liabilities to Capital Biolase Inc. BIOL|Short-Term Debt to Equity Dynatronics Corporation (DYNT)|paragon28.com - Short-Term Debt to Capital Ratio|INVO Bioscience - Short-Term Debt to Equity Ratio